A detailed history of Lcm Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Lcm Capital Management Inc holds 19,488 shares of PFE stock, worth $542,351. This represents 0.35% of its overall portfolio holdings.

Number of Shares
19,488
Previous 19,632 0.73%
Holding current value
$542,351
Previous $565,000 4.42%
% of portfolio
0.35%
Previous 0.41%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$25.89 - $29.73 $3,728 - $4,281
-144 Reduced 0.73%
19,488 $540,000
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $4,886 - $6,346
-187 Reduced 0.94%
19,632 $565,000
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $3,947 - $4,613
123 Added 0.62%
19,819 $657,000
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $10,872 - $12,578
301 Added 1.55%
19,696 $722,000
Q1 2023

May 01, 2023

BUY
$39.39 - $51.28 $24,461 - $31,844
621 Added 3.31%
19,395 $791,000
Q4 2022

Jan 24, 2023

BUY
$41.75 - $54.5 $375 - $490
9 Added 0.05%
18,774 $0
Q3 2022

Oct 14, 2022

SELL
$43.76 - $53.42 $2,275 - $2,777
-52 Reduced 0.28%
18,765 $821,000
Q2 2022

Jul 28, 2022

SELL
$46.53 - $55.17 $4,001 - $4,744
-86 Reduced 0.45%
18,817 $987,000
Q1 2022

Apr 18, 2022

BUY
$45.75 - $56.69 $5,993 - $7,426
131 Added 0.7%
18,903 $979,000
Q4 2021

Jan 24, 2022

BUY
$41.32 - $61.25 $21,073 - $31,237
510 Added 2.79%
18,772 $1.11 Million
Q3 2021

Oct 15, 2021

SELL
$39.25 - $50.42 $10,048 - $12,907
-256 Reduced 1.38%
18,262 $785,000
Q2 2021

Jul 21, 2021

BUY
$35.91 - $40.68 $134,375 - $152,224
3,742 Added 25.32%
18,518 $725,000
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $14,300 - $16,127
-427 Reduced 2.81%
14,776 $535,000
Q4 2020

May 12, 2021

BUY
$33.47 - $42.56 $508,844 - $647,039
15,203 New
15,203 $559,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lcm Capital Management Inc Portfolio

Follow Lcm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lcm Capital Management Inc with notifications on news.